Healthcare101

 The global MRI Systems Market , valued at US$6.15 billion in 2024, is forecasted to grow at a robust CAGR of 6.5%, reaching US$6.56 billion in 2025 and an impressive US$9.01 billion by 2030. The market for MRI systems is expected to grow significantly due to the rising burden of diseases, particularly neurological and musculoskeletal conditions, which are projected to increase in the coming years. The growing aging population, along with the increasing prevalence of chronic diseases like cancer, is likely to raise the demand for MRI systems worldwide. Additionally, regulatory support in the form of encouragement for innovations and more favourable reimbursement policies will contribute to the growth of the MRI systems market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=99 Browse in-depth TOC on “MRI Systems Market” 300 — Tables 50 — Figures 180 — Pages By Based on field strength, The global MRI systems market is categorized based on field strengt...

  The global cell culture market is witnessing strong growth, driven by the rising demand for advanced therapeutics, regenerative medicine, and innovations in bioprocessing technologies. Valued at US$27.92 billion in 2024 , the market increased to US$29.76 billion in 2025 and is projected to grow at a CAGR of 11.2% between 2025 and 2030, reaching a valuation of US$50.69 billion by 2030 . This rapid expansion highlights the growing reliance on cell-based systems for drug discovery, vaccine production, and regenerative medicine. The adoption of single-use technologies, coupled with the rising demand for monoclonal antibodies (mAbs) and biosimilars , is accelerating the usage of mammalian cell lines and cell culture products. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=559 Global Forecast and Key Opportunities to 2030 The cell culture market outlook to 2030 presents attractive opportunities for both established and emerging players. Grow...

  Market Overview The global injection pen market is a significant segment within the broader drug delivery systems industry. Injection pens are prefilled or reusable devices designed for self-administration of medication, offering convenience, accuracy, and ease of use compared to traditional syringes. These devices are particularly popular among patients with chronic conditions requiring regular injections, such as diabetes, rheumatoid arthritis, and growth hormone deficiencies. Download PDF Brochure Market Forecast and Growth Projections The global injection pen market, valued at US$43.8 billion in 2023, stood at US$47.0 billion in 2025 and is projected to advance at a resilient CAGR of 7.9% from 2024 to 2030, culminating in a forecasted valuation of US$74.1 billion by the end of the period.  Key Growth Drivers Several factors are contributing to the anticipated growth of the injection pen market: Rising Prevalence of Chronic Diseases: The increasing...

 The global market for human leukocyte antigen (HLA) typing is entering a transformative growth phase, driven by technological innovation, rising organ transplant procedures, and increasing awareness of organ donation. Valued at US $1.6 billion in 2024 , the market rose to US $1.7 billion in 2025 and is forecasted to expand at a CAGR of 6.0% , reaching US $2.3 billion by 2030 . This upward trajectory highlights how crucial accurate HLA typing has become for successful transplantation and precision diagnostics worldwide. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39129877 Why HLA Typing Matters More Than Ever HLA typing plays a vital role in determining compatibility between donors and recipients during organ and stem cell transplantation. By ensuring genetic matching at the HLA level, healthcare providers can minimize the risk of graft rejection and improve long-term transplant outcomes. It also helps prevent severe complications like gra...

 The global  eClinical Solutions Market  is expected to grow from USD 11.6 billion in 2024 to USD 22.1 billion by 2029, at a CAGR of 13.7%. eClinical solutions have significantly enhanced clinical trial efficiency, site performance, and cost-effectiveness compared to traditional methods, driving their market growth. These solutions, including electronic data capture (EDC) and clinical data management systems (CDMS), streamline operations and ensure regulatory compliance, benefiting contract research organizations (CROs), researchers, and pharmaceutical companies. Despite high implementation costs and concerns over patient privacy, the market is expanding due to increased adoption of novel software, rising clinical trials in developing countries, and the growing need for efficient data management. The electronic clinical outcome assessment (eCOA) solutions segment is expected to grow the fastest, driven by improved data accuracy and patient engagement. ...

 The mRNA synthesis and manufacturing market is projected to reach USD 2.96 billion by 2029 from USD 2.23 billion in 2024, at a CAGR of 5.8% from 2024 to 2029. The market growth is fueled by rising demand in clinical trials for mRNA vaccines, along with the increased outsourcing of mRNA synthesis and production. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105705347 Browse in-depth TOC on “mRNA Synthesis & Manufacturing Market” 250 — Tables 50 — Figures 250 — Pages KEY TAKEAWAYS The North America mRNA synthesis & manufacturing market accounted for a 47.1% revenue share in 2024. By product, the instruments segment is expected to register the highest CAGR of 5.8% By service, the mRNA synthesis & modification services segment is expected to register the highest CAGR of 7.6% By application, the cell & gene therapies segment is projected to grow at the fastest rate from 2024 to 2029. By end user (product), the pharmaceutical & biotec...